Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05143424 · ClinicalTrials.gov registry record · Phase 1

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

A Phase 1 study of Opioid Use Disorder, sponsored by National Institute on Drug Abuse (NIDA).

Recruiting
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT05143424 is a Phase 1 study of Opioid Use Disorder that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 60 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05143424, a Phase 1 study of Opioid Use Disorder, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).

RECRUITING
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to analyze drug-drug interactions of CBD on co-administered Morphine as first step in understanding CBD-opioid interactions.

Conditions Studied

Opioid Use Disorder

Interventions

  • DRUG Morphine Sulfate

Study Locations (1)

Kansas

  • AltaSciences - Overland Park

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-11-04
Est. Completion 2024-12-01
Phase Phase 1

Sponsor

National Institute on Drug Abuse (NIDA)

335 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05143424

The ClinicalTrials.gov registry entry for NCT05143424 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Morphine Sulfate is the first listed.

NCT05143424 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT05143424 about?

NCT05143424 is a clinical study titled "Evaluation of the Interactions of Cannabidiol (CBD) With Morphine". The purpose of this study is to analyze drug-drug interactions of CBD on co-administered Morphine as first step in understanding CBD-opioid interactions.

What is the current status of trial NCT05143424?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-11-04. Estimated completion is 2024-12-01.

What conditions does trial NCT05143424 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05143424?

The interventions under investigation include: Morphine Sulfate (DRUG).

Who is sponsoring clinical trial NCT05143424?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05143424 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.